Waters Corporation (WAT)
NYSE: WAT · Real-Time Price · USD
374.70
-1.61 (-0.43%)
Dec 19, 2025, 3:53 PM EST - Market open
Waters Market Cap
Waters has a market cap or net worth of $22.31 billion as of December 19, 2025. Its market cap has decreased by -2.92% in one year.
Market Cap
22.31B
Enterprise Value
23.46B
1-Year Change
-2.92%
Ranking
Category
Stock Price
$374.70
Market Cap Chart
Since December 1, 1998, Waters's market cap has increased from $2.35B to $22.31B, an increase of 849.71%. That is a compound annual growth rate of 8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 22.40B | 1.71% |
| Dec 31, 2024 | 22.03B | 13.16% |
| Dec 29, 2023 | 19.47B | -4.35% |
| Dec 30, 2022 | 20.35B | -10.51% |
| Dec 31, 2021 | 22.74B | 48.14% |
| Dec 31, 2020 | 15.35B | 1.97% |
| Dec 31, 2019 | 15.06B | 5.36% |
| Dec 31, 2018 | 14.29B | -7.00% |
| Dec 29, 2017 | 15.37B | 41.89% |
| Dec 30, 2016 | 10.83B | -1.47% |
| Dec 31, 2015 | 10.99B | 17.08% |
| Dec 31, 2014 | 9.39B | 10.27% |
| Dec 31, 2013 | 8.51B | 12.38% |
| Dec 31, 2012 | 7.58B | 14.17% |
| Dec 30, 2011 | 6.64B | -6.51% |
| Dec 31, 2010 | 7.10B | 20.97% |
| Dec 31, 2009 | 5.87B | 62.84% |
| Dec 31, 2008 | 3.60B | -54.62% |
| Dec 31, 2007 | 7.94B | 59.78% |
| Dec 29, 2006 | 4.97B | 18.80% |
| Dec 30, 2005 | 4.18B | -26.01% |
| Dec 31, 2004 | 5.65B | 40.43% |
| Dec 31, 2003 | 4.03B | 43.15% |
| Dec 31, 2002 | 2.81B | -44.51% |
| Dec 31, 2001 | 5.07B | -53.04% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.99B |
| Johnson & Johnson | 504.27B |
| AbbVie | 395.31B |
| UnitedHealth Group | 302.73B |
| AstraZeneca | 281.22B |
| Novartis AG | 259.57B |
| Merck & Co. | 243.91B |
| Abbott Laboratories | 220.59B |